Zacks Investment Research
26 Jun 2026, 13:45 UTC · 1h ago
Bayer (BAYRY) Moves 17.0% Higher: Will This Strength Last?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
26 Jun 2026, 13:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The U.S. Supreme Court ruled 7-2 that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law failure-to-warn claims regarding Roundup. — This landmark ruling is expected to significantly reduce litigation costs and legal liabilities for Bayer, removing a massive financial overhang.
+0.80Bayer's upcoming quarterly earnings per share (EPS) are expected to be $0.23, a 34.3% decrease year-over-year. — A significant decline in year-over-year earnings suggests weakening fundamental profitability despite the legal victory.
-0.30Bayer's projected quarterly revenues are $12.32 billion, representing a modest increase of 1.1% over the prior year. — Stagnant revenue growth provides little fundamental momentum to support a long-term price increase.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
CNBC
3h ago
